These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 30481595)

  • 41. The impact of levofloxacin prophylaxis on empiric intravenous antibiotic use in pediatric hematopoietic stem cell transplant recipients.
    Prodanuk M; Timberlake K; Koo A; Chopra Y; Wall DA; Science M
    Pediatr Blood Cancer; 2024 Aug; 71(8):e31059. PubMed ID: 38721864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fluoroquinolone prophylaxis in autologous hematopoietic stem cell transplant recipients.
    Modi D; Jang H; Kim S; Surapaneni M; Sankar K; Deol A; Ayash L; Bhutani D; Lum LG; Ratanatharathorn V; Manasa R; Mellert K; Chandrasekar P; Uberti JP
    Support Care Cancer; 2017 Aug; 25(8):2593-2601. PubMed ID: 28365897
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characteristics of gram-negative bacteremia during febrile neutropenia among allogeneic hematopoietic stem cell transplant recipients on levofloxacin prophylaxis.
    Ogura S; Kimura M; Takagi S; Mitsuki T; Yuasa M; Kageyama K; Kaji D; Nishida A; Taya Y; Ishiwata K; Yamamoto H; Asano-Mori Y; Yamamoto G; Uchida N; Wake A; Taniguchi S; Araoka H
    Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):941-948. PubMed ID: 33185742
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The rise of ampicillin-resistant Enterococcus faecium high-risk clones as a frequent intestinal colonizer in oncohaematological neutropenic patients on levofloxacin prophylaxis: a risk for bacteraemia?
    Sánchez-Díaz AM; Cuartero C; Rodríguez JD; Lozano S; Alonso JM; Rodríguez-Domínguez M; Tedim AP; Del Campo R; López J; Cantón R; Ruiz-Garbajosa P
    Clin Microbiol Infect; 2016 Jan; 22(1):59.e1-59.e8. PubMed ID: 26321668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preventive strategies for central line-associated bloodstream infections in pediatric hematopoietic stem cell transplant recipients.
    Barrell C; Covington L; Bhatia M; Robison J; Patel S; Jacobson JS; Buet A; Graham PL; Saiman L
    Am J Infect Control; 2012 Jun; 40(5):434-9. PubMed ID: 21907455
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ciprofloxacin versus levofloxacin prophylaxis in hematopoietic stem cell transplantation: A randomized trial.
    Farhan S; Mazur I; Hartzell S; Xie P; Neme K; German A; Mikulandric N; Patel K; Wu M; Kortam N; Yaseen A; Sweidan A; Latack K; Emole J; Peres E; Abidi MH; Ramesh M
    Int J Infect Dis; 2024 Jul; 147():107172. PubMed ID: 39019103
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Applying a risk prediction model for bloodstream infection in a febrile, nonseverely neutropenic cohort of pediatric stem cell transplant patients.
    Jackson K; Anderson V; Zhao Z; Kitko CL; Connelly JA; Ho RH; Banerjee R; Dulek DE; Friedman DL; Esbenshade AJ
    Cancer; 2023 May; 129(10):1591-1601. PubMed ID: 36828805
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prophylactic antibiotics eliminate bacteremia and allow safe outpatient management following high-dose chemotherapy and autologous stem cell rescue.
    Meisenberg B; Gollard R; Brehm T; McMillan R; Miller W
    Support Care Cancer; 1996 Sep; 4(5):364-9. PubMed ID: 8883230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Results of Levofloxacin Prophylaxis Timing in Autologous and Allogeneic Stem Cell Transplantation: A Retrospective Cohort Study.
    Özkan SG; Safaei S; Kimiaei A; Çınar Y; Sönmezoğlu M; Özkan HA
    Cureus; 2024 Apr; 16(4):e57598. PubMed ID: 38707020
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxis.
    De Rosa FG; Motta I; Audisio E; Frairia C; Busca A; Di Perri G; Marmont F
    BMC Infect Dis; 2013 Dec; 13():563. PubMed ID: 24289496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical impact of fluoroquinolone-resistant Escherichia coli in the fecal flora of hematological patients with neutropenia and levofloxacin prophylaxis.
    Chong Y; Shimoda S; Yakushiji H; Ito Y; Aoki T; Miyamoto T; Kamimura T; Shimono N; Akashi K
    PLoS One; 2014; 9(1):e85210. PubMed ID: 24465506
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy of anti-fungal but not anti-bacterial prophylaxis in intensive primary AML therapy: a real-world, retrospective comparative single-centre study.
    Gerber B; Köppel J; Paul M; Nguyen-Kim TD; Frauenfelder T; Nair G; Schanz U; Manz MG
    Swiss Med Wkly; 2014; 144():w13985. PubMed ID: 25055166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Levofloxacin versus Cefpodoxime for Antibacterial Prophylaxis in Allogeneic Stem Cell Transplantation.
    Doan VP; Yeh JC; Gulbis AM; Aitken SL; Ariza-Heredia E; Ahmed S
    Biol Blood Marrow Transplant; 2019 Aug; 25(8):1637-1641. PubMed ID: 31002991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [The Preventive Effect of Levofloxacin Combined with G-CSF or Only G-CSF Supportive Therapy on Infection in Autologous Hematopoietic Stem Cell Transplantation].
    Wang XW; Yang LP; Yao Q; Zhao J; He SL; Ma LM; Wei JN; Tian WW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):906-910. PubMed ID: 38926987
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Levofloxacin vs. ciprofloxacin plus phenethicillin for the prevention of bacterial infections in patients with haematological malignancies.
    Timmers GJ; Simoons-Smit AM; Leidekker ME; Janssen JJ; Vandenbroucke-Grauls CM; Huijgens PC
    Clin Microbiol Infect; 2007 May; 13(5):497-503. PubMed ID: 17263835
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Ciprofloxacin prophylaxis during autologous stem cell transplantation for multiple myeloma in patients with a high rate of fluoroquinolone-resistant gram-negative bacteria colonization.
    Zavrelova A; Paterova P; Gabalec F; Zak P; Radocha J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Jun; 163(2):161-165. PubMed ID: 30198521
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Levofloxacin for Antibacterial Prophylaxis in Pediatric Patients With Acute Myeloid Leukemia or Undergoing Hematopoietic Stem Cell Transplantation.
    Patel B; Noda A; Godbout E; Stevens M; Noda C
    J Pediatr Pharmacol Ther; 2020; 25(7):629-635. PubMed ID: 33041718
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of bacterial infections in allogeneic hematopoietic stem cell transplant recipients who received prophylactic levofloxacin with either penicillin or doxycycline.
    Therriault BL; Wilson JW; Barreto JN; Estes LL
    Mayo Clin Proc; 2010 Aug; 85(8):711-8. PubMed ID: 20675508
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of levofloxacin as an antibacterial prophylaxis for acute leukemia patients receiving intensive chemotherapy: a systematic review and meta-analysis.
    Owattanapanich W; Chayakulkeeree M
    Hematology; 2019 Dec; 24(1):362-368. PubMed ID: 30880638
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bacteremia during neutropenic episodes in children undergoing hematopoietic stem cell transplantation with ciprofloxacin and penicillin prophylaxis.
    Choeyprasert W; Hongeng S; Anurathapan U; Pakakasama S
    Int J Hematol; 2017 Feb; 105(2):213-220. PubMed ID: 27771837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.